Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorROUSSEAU, Antoine
dc.contributor.authorBURREL, Sonia
dc.contributor.authorGUEUDRY, Julie
dc.contributor.authorDEBACK, Claire
dc.contributor.authorHAIGH, Oscar
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSCHWEITZER, Cedric
ORCID: 0000-0002-2162-9479
IDREF: 133631583
dc.contributor.authorBOUTOLLEAU, David
dc.contributor.authorLABETOULLE, Marc
dc.date.accessioned2022-02-16T15:17:54Z
dc.date.available2022-02-16T15:17:54Z
dc.date.issued2022-01-13
dc.identifier.issn1879-1891 (Electronic) 0002-9394 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/124746
dc.description.abstractEnPurpose To describe the clinical and virological profiles of patients with herpes simplex keratitis (HSK) caused by acyclovir-resistant (ACV(R)) strains of herpes simplex virus 1 (HSV-1). Design Multicenter retrospective case series. Methods HSV-1 resistance to ACV was confirmed using sequencing of genes encoding HSV-1 thymidine kinase (TK) and DNA polymerase (DNA pol). Data were collected on the number of HSK episodes before and after the diagnosis of resistance, ocular findings including the type of HSK, immune status of patients, antiviral treatments and HSV-1 genotypic resistance profiles. Results This study evaluated 18 HSK patients (13 males, 5 females, 66.8±4.7 years) with ACV(R) HSV-1 positive ocular samples. Genotypic resistance testing was performed due to frequent recurrences despite adequate antiviral prophylaxis (AVP) (N=13, 72%), or poor response to suppressive antiviral therapy (N=5, 28%). Resistance mutations were found in the TK (N=15, 83%) or in the DNA pol gene (N=3, 17%). Prior to the diagnosis of resistance, duration of disease was 29.8±20.4 years with more than 10 HSK recurrences in 15 patients (83%). The number of recurrences between the first episode and the diagnosis of resistance was significantly lower in immunocompromised patients (N=6, 33%), than in immunocompetent patients (N=12; 67%) (11.5±4.9 versus 16.4±1.9, P=0.05). Conclusion HSV-1 resistance to ACV must be suspected in HSK patients with recurrences despite AVP and/or in cases that respond poorly to a suppressive antiviral regimen. Immunocompromised patients and/or those with a long-standing disease, may be particularly at risk for developing resistance.
dc.language.isoENen_US
dc.subject.enHerpes simplex keratitis
dc.subject.enAntiviral
dc.subject.enResistance
dc.subject.enAcyclovir
dc.subject.enValacyclovir
dc.title.enAcyclovir-resistant HSV-1 keratitis: a concerning and emerging clinical challenge
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.ajo.2022.01.010en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35033543en_US
bordeaux.journalAmerican Journal of Ophthalmologyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03577322
hal.version1
hal.date.transferred2022-02-16T15:17:56Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=American%20Journal%20of%20Ophthalmology&rft.date=2022-01-13&rft.eissn=1879-1891%20(Electronic)%200002-9394%20(Linking)&rft.issn=1879-1891%20(Electronic)%200002-9394%20(Linking)&rft.au=ROUSSEAU,%20Antoine&BURREL,%20Sonia&GUEUDRY,%20Julie&DEBACK,%20Claire&HAIGH,%20Oscar&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record